The financial increase India might face from halting purchases of Russian oil.
India, a key player in the global supply chain for affordable and essential medicines, finds itself at a crossroads as it navigates the complexities of international trade and energy security.
According to a report by the State Bank of India (SBI), India imported 88 million metric tonnes of crude from Russia in the last fiscal year, accounting for 35.1% of its total oil imports. The recent imposition of additional US tariffs on Indian goods, due to continuous imports of Russian oil, has increased economic pressure on the country.
The SBI report also suggests that if India stops buying Russian crude oil, the fuel bill could increase by USD 9 billion in the current financial year and USD 11.7 billion in the next. To mitigate this, Indian refiners have turned to crude suppliers in the United States, West Africa, and Azerbaijan.
However, the price of Urals, the OPEC+ producer's flagship oil, is more than $5 a barrel cheaper than Dated Brent. This significant price difference has made Russian crude an attractive option for India, supporting its energy security and cost-effectiveness, helping control fuel costs. Halting these imports could push up global and domestic oil prices, increasing costs for Indian consumers and industries.
In the pharmaceutical sector, India's 35% share in generic drugs tariff in the US market could significantly impact US citizens. The SBI report warns that tariffs on pharmaceutical exports may reduce competitiveness in the world's largest pharma market and put pressure on profit margins due to the inability to pass on costs. Possible tariffs on pharmaceutical exports from India to the US may hit earnings of firms by 5 percent to 10 percent this financial year.
Prime Minister Narendra Modi has expressed his readiness to bear a significant personal cost if necessary to protect the interests of farmers, fishermen, and the dairy sector in India. This statement indicates the government's commitment to safeguarding domestic industries from the potential impacts of trade decisions.
The interplay with US sanctions targeting Russia and India's strategic balancing act with Russia, the US, and China complicates India's decision-making, with potential impacts on trade, diplomacy, and energy security. According to experts like former RBI Governor Raghuram Rajan, while India could manage higher oil prices if Russian crude imports were cut, the real concern lies in the political costs domestically, as yielding to US pressure may be unpopular in India’s democratic context.
In summary, stopping Russian crude imports would likely increase energy costs for India but would not be economically catastrophic. The greater consequences might be political and diplomatic, related to India's positioning between Western sanctions and its energy needs. In the pharmaceutical sector, tariffs could impact competitiveness and profit margins, potentially affecting the affordability and availability of life-saving drugs for both Indians and US citizens.
- In the realm of finance, the SBI report suggests that if India were to stop buying Russian crude oil, the increase in fuel costs could reach up to USD 11.7 billion in the next financial year.
- Meanwhile, in the pharmaceutical industry, tariffs on pharmaceutical exports from India to the US may hit earnings of firms by 5 percent to 10 percent this financial year, potentially affecting the affordability and availability of life-saving drugs for both Indians and US citizens.
- Politically, experts like former RBI Governor Raghuram Rajan warn that while India could manage higher oil prices if Russian crude imports were cut, the real concern lies in the political costs domestically, as yielding to US pressure may be unpopular in India’s democratic context.
